Total Payments
$41,596
2024 Payments
$21,014
Companies
9
Transactions
62
Medicare Patients
436
Medicare Billing
$92,129
Payment Breakdown by Category
Consulting$33,975 (81.7%)
Travel$4,979 (12.0%)
Food & Beverage$2,118 (5.1%)
Other$525.00 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $33,975 | 12 | 81.7% |
| Travel and Lodging | $4,979 | 17 | 12.0% |
| Food and Beverage | $2,118 | 32 | 5.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $525.00 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $15,298 | 22 | $0 (2024) |
| Eisai Inc. | $14,386 | 18 | $0 (2024) |
| F. Hoffmann-La Roche AG | $4,765 | 2 | $0 (2024) |
| Eli Lilly and Company | $3,284 | 3 | $0 (2022) |
| Genentech USA, Inc. | $1,800 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,195 | 8 | $0 (2019) |
| Grifols Biologicals LLC | $686.92 | 6 | $0 (2019) |
| Stryker Corporation | $148.93 | 1 | $0 (2022) |
| ANI Pharmaceuticals, Inc. | $32.73 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21,014 | 28 | Lilly USA, LLC ($12,673) |
| 2023 | $10,740 | 12 | Eisai Inc. ($10,740) |
| 2022 | $5,726 | 6 | Lilly USA, LLC ($2,625) |
| 2021 | $2,234 | 2 | Eli Lilly and Company ($2,234) |
| 2019 | $712.37 | 7 | Grifols Biologicals LLC ($686.92) |
| 2017 | $1,170 | 7 | Novartis Pharmaceuticals Corporation ($1,170) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $32.73 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/09/2024 | Lilly USA, LLC | KISUNLA (Drug) | Consulting Fee | Cash or cash equivalent | $7,350.00 | General |
| Category: Neuroscience | ||||||
| 10/09/2024 | Lilly USA, LLC | KISUNLA (Drug) | Consulting Fee | Cash or cash equivalent | $1,850.00 | General |
| Category: Neuroscience | ||||||
| 10/02/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $1,231.95 | General |
| 10/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Travel and Lodging | In-kind items and services | $352.33 | General |
| Category: Neuroscience | ||||||
| 10/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Travel and Lodging | In-kind items and services | $352.33 | General |
| Category: Neuroscience | ||||||
| 10/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Travel and Lodging | In-kind items and services | $243.20 | General |
| Category: Neuroscience | ||||||
| 10/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Travel and Lodging | In-kind items and services | $233.20 | General |
| Category: Neuroscience | ||||||
| 10/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $132.57 | General |
| Category: Neuroscience | ||||||
| 10/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $59.11 | General |
| Category: Neuroscience | ||||||
| 10/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $59.11 | General |
| Category: Neuroscience | ||||||
| 10/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $54.18 | General |
| Category: Neuroscience | ||||||
| 10/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $54.18 | General |
| Category: Neuroscience | ||||||
| 10/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Travel and Lodging | In-kind items and services | $46.17 | General |
| Category: Neuroscience | ||||||
| 10/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Neuroscience | ||||||
| 10/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Neuroscience | ||||||
| 10/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Neuroscience | ||||||
| 10/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Neuroscience | ||||||
| 10/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Neuroscience | ||||||
| 08/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $121.78 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $68.34 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $39.76 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $23.61 | General |
| Category: Neurology | ||||||
| 07/28/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Neuroscience | ||||||
| 07/27/2024 | F. Hoffmann-La Roche AG | — | Consulting Fee | Cash or cash equivalent | $4,485.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 105 | 214 | $55,510 | $23,780 |
| 2022 | 3 | 93 | 224 | $54,855 | $21,296 |
| 2021 | 4 | 116 | 239 | $62,135 | $24,163 |
| 2020 | 3 | 122 | 247 | $60,070 | $22,890 |
Total Patients
436
Total Services
924
Medicare Billing
$92,129
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 37 | 84 | $25,620 | $11,471 | 44.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 40 | 94 | $19,270 | $8,937 | 46.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 18 | $6,300 | $1,973 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 18 | $4,320 | $1,399 | 32.4% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 38 | 121 | $24,805 | $9,915 | 40.0% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 40 | 82 | $25,010 | $9,874 | 39.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 21 | $5,040 | $1,507 | 29.9% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 48 | 103 | $31,415 | $12,628 | 40.2% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 43 | 102 | $20,910 | $8,423 | 40.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 15 | $5,250 | $1,616 | 30.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 19 | $4,560 | $1,497 | 32.8% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2020 | 51 | 96 | $29,280 | $11,433 | 39.0% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 56 | 129 | $26,445 | $10,198 | 38.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 22 | $4,345 | $1,259 | 29.0% |
About Dr. Thomas Obisesan, MD
Dr. Thomas Obisesan, MD is a Geriatric Medicine healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295894426.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Obisesan, MD has received a total of $41,596 in payments from pharmaceutical and medical device companies, with $21,014 received in 2024. These payments were reported across 62 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($33,975).
As a Medicare-enrolled provider, Obisesan has provided services to 436 Medicare beneficiaries, totaling 924 services with total Medicare billing of $92,129. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Location Washington, DC
- Active Since 12/06/2006
- Last Updated 11/22/2019
- Taxonomy Code 207RG0300X
- Entity Type Individual
- NPI Number 1295894426
Products in Payments
- KISUNLA (Drug) $10,916
- Leqembi (Drug) $8,173
- CNP520 (Drug) $943.85
- Albutein (Biological) $686.92
- CORE (Device) $148.93
- PURIFIED CORTROPHIN GEL (Drug) $32.73
- API015 (Drug) $25.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Medicine Doctors in Washington
Dr. Raj Mathur, Md, MD
Geriatric Medicine — Payments: $10,080
Geriatric Medicine $10,080
Mikhail Kogan, Md, MD
Geriatric Medicine — Payments: $2,153
Geriatric Medicine $2,153
Dr. David King, M.d, M.D
Geriatric Medicine — Payments: $1,572
Geriatric Medicine $1,572
Victoria Fedorova, M.d, M.D
Geriatric Medicine — Payments: $1,014
Geriatric Medicine $1,014
Dr. Michael Grady, M.d, M.D
Geriatric Medicine — Payments: $612.64
Geriatric Medicine $612.64
Dr. Elizabeth Cobbs, Md, MD
Geriatric Medicine — Payments: $371.41
Geriatric Medicine $371.41